![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
Fujifilm partners with Dr. Reddys and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
FUJIFILM Corporation partners with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company headquartered in India and Global Response Aid, a global provider of medical...
Packaging & Labelling
SCHOTT delivers pharma vials to package 2 billion doses of COVID-19 vaccines
SCHOTT supports the world’s fight against COVID-19 with vials capable of holding up to 2 billion vaccination doses. The glassmaker and pharma packaging specialist...
News
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced a strategic partnership with the University of Natural Resources and Life...
News
Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial
Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed...
Clinical Trials
LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has deployed...
Clinical Trials
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of...
News
PrecisionLife identifies 68 genes associated with high risk of severe COVID-19
Scientists from UK-headquartered AI precision medicine company, PrecisionLife, have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read